Bioactive Food Peptides
The hidden pharmacology of food — bioactive peptide fragments released during digestion of milk, meat, fish, and plant proteins, including casomorphins, lactokinins, and ACE-inhibitory peptides.
Peptide fragments (typically 2–20 amino acids) encrypted within food protein sequences and liberated by digestive enzymes or fermentation, some with documented blood-pressure-lowering, opioid, or immune-modulating effects at physiological concentrations.
Mechanism of action
Mechanism varies by peptide class: (1) ACE-inhibitory peptides (VPP, IPP from casein) lower blood pressure by inhibiting angiotensin-converting enzyme; (2) Casomorphins (β-casomorphin-7) are μ-opioid receptor agonists; (3) Immunopeptides (lactoferricin) have antimicrobial and immunomodulatory effects; (4) Antioxidant peptides scavenge free radicals via His, Trp, Tyr, Cys, and Met residues.
Primary uses
- Functional food research
- Antihypertensive nutraceuticals
- Sports nutrition (whey peptides)
- Gut health and immune modulation
Typical dosing
Varies widely. ACE-inhibitory milk peptides: ~3–5 mg VPP+IPP/day. Whey protein hydrolysate: 20–40 g/day. Context-dependent.
Regulatory status
Individual products (e.g., Lactobacillus-fermented milk with VPP/IPP) approved as FOSHU (Foods for Specified Health Uses) in Japan. Not FDA-approved as drugs. Some marketed as dietary supplements.
References
- [review] Korhonen H, Pihlanto A. "Bioactive peptides: production and functionality." Int Dairy J, 2006;16:945-960.
- [review] Cicero AFG, et al. "Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials." J Hum Hypertens, 2011;25:425-436.
Related peptides
This entry is for educational purposes only and does not constitute medical advice. Dosing information reflects published regulatory or research data and is not a recommendation. Many compounds described here are not approved for human use in the United States. Consult a licensed medical professional before considering any peptide therapy.